Furthermore, S100B—mainly concentrated in astrocytes—is recognized as a reliable biomarker of active neuronal distress in Alzheimer’s disease, Parkinson’s disease, ALS, or multiple sclerosis [18]. This evidence concerns the gene S100B and early-onset autosomal dominant Alzheimer disease.